We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Paper-Based TB Test Could Increase Diagnoses Worldwide

By LabMedica International staff writers
Posted on 26 Sep 2017
Print article
Image: Scientists have developed a rapid, paper-based TB text that allows results to be read with a smartphone (Photo courtesy of Wikimedia Commons).
Image: Scientists have developed a rapid, paper-based TB text that allows results to be read with a smartphone (Photo courtesy of Wikimedia Commons).
In resource-limited areas, equipment requirements and long wait times for results are obstacles to early diagnosis and treatment of tuberculosis (TB). To tackle this problem, scientists have developed a rapid colorimetric TB assay using gold nanoparticles on a paper-based device than enables results to be read with a smartphone.

Most of deaths from TB occur in low- and middle-income countries and remote areas. Conventional methods such as sputum smear microscopy, chest X-rays, and molecular-based tests require equipment, electricity, and specialized personnel. So lead researcher Chien-Fu Chen, professor at National Taiwan University (Taiwan), and colleagues from Chang Gung Memorial Hospital (Taiwan) and elsewhere in Taiwan, set out to come up with a more practical diagnostic test that can be read with a smartphone, a technology that is becoming increasingly available in emerging economies.

The researchers combined gold nanoparticles with single-stranded DNA (ssDNA) sequences that bind to the genetic material of Mycobacterium tuberculosis. These nanoparticles were then incorporated into a paper-based device. Adding even a minute amount of lab-derived, double-stranded DNA (dsDNS) from M. tuberculosis changed the color of the test spots within an hour. Furthermore, multiple tests could be performed simultaneously with a 60 min turnaround time.

A smartphone camera was used to analyze the color change to determine the bacterial concentration. The researchers also tested a tissue sample from an infected patient to further demonstrate that the device could be used in the field.

The study, by Tsai TT et al, was published September 13, 2017, in the journal ACS Sensors.

Related Links:
National Taiwan University
Chang Gung Memorial Hospital

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: The device can serve as a sample pretreatment tool for cytological diagnosis of malignant effusions (Photo courtesy of Microsystems & Nanoengineering: Zhu, Z., Ren, H., Wu, D. et al.)

Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities

Tumor cell clusters are increasingly recognized as crucial in cancer pathophysiology, with growing evidence of their increased resistance to treatment and higher metastatic potential compared to single tumor cells.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.